75 related articles for article (PubMed ID: 1947617)
1. [The recurrence of duodenal ulcer in patients undergoing treatment with ranitidine and placebo. A multicenter study].
Villalobos JJ; Nava AA; Elizondo J; Gallo S; Guerrero C; Vargas F; Barrera A; Centeno F; Marín E; Peña F
Rev Gastroenterol Mex; 1991; 56(2):65-9. PubMed ID: 1947617
[TBL] [Abstract][Full Text] [Related]
2. [Intermittent treatment or preventive treatment of recurrence in duodenal ulcer disease? A controlled, double-blind study with 150 mg ranitidine daily for one year].
Mignon M; Ruszniewski P; Pappo M; Alberola B; Georges D
Gastroenterol Clin Biol; 1990; 14(10):732-8. PubMed ID: 2262119
[TBL] [Abstract][Full Text] [Related]
3. Safety of ranitidine maintenance treatment of duodenal ulcer.
Boyd EJ; Wilson JA; Wormsley KG
Scand J Gastroenterol; 1984 May; 19(3):394-400. PubMed ID: 6330871
[TBL] [Abstract][Full Text] [Related]
4. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
5. Ranitidine in the treatment of peptic ulcer.
Makalinao AU; Zaño FM
Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
[TBL] [Abstract][Full Text] [Related]
6. [Controlled study with ranitidine for the prevention of recurrent duodenal ulcer].
Ocaña Andrade E; Porras Katz JC; Beltrán Escobar G; Jáuregui Garduño JL
Rev Gastroenterol Mex; 1997; 62(2):94-7. PubMed ID: 9471669
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
[TBL] [Abstract][Full Text] [Related]
8. [Dose comparative study with ranitidine in the therapy and prevention of duodenal ulcer].
Paul F; Neuhaus H; Homann J; Kamenisch W; Eimiller A
Z Gastroenterol; 1986 Mar; 24(3):141-8. PubMed ID: 3085363
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic double-blind controlled trial of ranitidine vs placebo in the short-term treatment of duodenal ulcer.
Dobrilla G; de Pretis G; Felder M; Chilovi F
Hepatogastroenterology; 1981 Feb; 28(1):49-52. PubMed ID: 6111528
[TBL] [Abstract][Full Text] [Related]
10. Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer--a controlled prospective double-blind trial.
Darle N; Almskog B; Falk A; Fredriksen B; Gamklou R; Ivarsson L; Karlström L
Ann Clin Res; 1984; 16(1):6-9. PubMed ID: 6331270
[TBL] [Abstract][Full Text] [Related]
11. [Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial].
Delvaux M; Hagège CG; Ribet A
Gastroenterol Clin Biol; 1989 Dec; 13(12):1055-9. PubMed ID: 2696659
[TBL] [Abstract][Full Text] [Related]
12. [Ranitidine, cimetidine and placebo in the short and longer term treatment of duodenal ulcer].
Klinger J; Maggiolo P; Goić A
Rev Med Chil; 1984 Apr; 112(4):337-41. PubMed ID: 6091211
[No Abstract] [Full Text] [Related]
13. Randomised double blind placebo controlled clinical trial of sucralfate and ranitidine in chronic duodenal ulcer.
Nair KV; Ramachandran TM; Thomas V; Rajindranath T
J Assoc Physicians India; 1990 Mar; 38(3):211-2. PubMed ID: 2202705
[TBL] [Abstract][Full Text] [Related]
14. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
Sevvel S; Ananthakrishnan N; Kate V
Trop Gastroenterol; 1996; 17(4):227-9. PubMed ID: 9094865
[TBL] [Abstract][Full Text] [Related]
15. Smoking as a risk factor for duodenal ulcer relapse. RUDER Study Group.
Breuer-Katschinski BD; Armstrong D; Goebell H; Arnold R; Classen M; Fischer M; Blum AL
Z Gastroenterol; 1995 Sep; 33(9):509-12. PubMed ID: 8525653
[TBL] [Abstract][Full Text] [Related]
16. Ranitidine in the maintenance therapy of gastro-duodenal ulcer disease: Polish open multicentre study.
Gibiński K; Nowak A; Gabryelewicz A; Szałaj W; Hasik J; Klincewicz H; Butruk E; Kosecki P; Pokora J; Radwan P
Hepatogastroenterology; 1984 Aug; 31(4):180-2. PubMed ID: 6090287
[TBL] [Abstract][Full Text] [Related]
17. Five-year maintenance treatment with ranitidine: effects on the natural history of duodenal ulcer disease.
Susi D; Neri M; Ballone E; Mezzetti A; Cuccurullo F
Am J Gastroenterol; 1994 Jan; 89(1):26-32. PubMed ID: 8273793
[TBL] [Abstract][Full Text] [Related]
18. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics.
Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M
Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591
[TBL] [Abstract][Full Text] [Related]
19. A multicenter, double-blind, randomized controlled study of omeprazole versus ranitidine in the treatment of duodenal ulcer in Israel.
Arber N; Avni Y; Eliakim R; Swissa A; Melzer E; Rachmilewitz D; Konikoff F
Isr J Med Sci; 1994 Oct; 30(10):757-61. PubMed ID: 7960688
[TBL] [Abstract][Full Text] [Related]
20. A comparative therapeutic trial of sucralfate and ranitidine in initial healing and relapse rate of duodenal ulcer.
Agrawal BK; Prasad RN; Kumar P
J Assoc Physicians India; 1990 Sep; 38 Suppl 1():720-2. PubMed ID: 2092028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
